STOCK TITAN

Arch Capital Group Ltd Form 4 Filings

ACGL NASDAQ

Every Form 4 that Arch Capital Group Ltd (ACGL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ACGL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACGL filings page.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. (ACGL) officer Francois Morin, CFO and Treasurer, reported an option exercise and same-day share sale. On 2026-08-18 he exercised 11,010 stock options at $27.0867 per share, receiving 11,010 common shares, and then sold 11,010 common shares at a weighted average price of $99.3214. Following these transactions, an indirect holding of 114,229 common shares is reported as held by a revocable trust for the benefit of his spouse; these shares were previously owned directly in a joint account. The Form 4 does not indicate use of a Rule 10b5-1 trading plan.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. director and chair John M. Pasquesi reported bona fide gifts of a total of 2,013,400 common shares of the company’s stock. The gifts were split into two transfers of 1,006,700 shares each at a stated price of $0.0000 per share.

After one gift, a revocable trust associated with him held 2,827,681 common shares, and a limited liability company associated with him held 214,993 shares after the other. He also reports additional indirect holdings through trusts and a family limited partnership, plus 3,076 shares held directly.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. director Brian S. Posner reported an open-market sale of 3,000 Depositary Shares, Series F, at a weighted average price of $19.66 per share. Each Depositary Share represents a 1/1,000th interest in a Series F Non-Cumulative Preferred Share, and this sale reduced his reported holdings of these Depositary Shares to zero.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. director Brian S. Posner reported an open-market sale of 2,000 Depositary Shares, Series G, on 2026-05-11 at a weighted average price of $17.1415 per share. Each Depositary Share represents a 1/1,000th interest in a Series G Non-Cumulative Preferred Share. Following this transaction, his direct holdings of these Depositary Shares were reduced to zero, indicating a full exit from this specific security class.

Rhea-AI Summary

Triplett Neal F reported acquisition or exercise transactions in this Form 4 filing.

Arch Capital Group Ltd. director Neal F. Triplett reported two share awards in the form of company common shares. On May 5, 2026, he received 1,327 restricted shares that will vest on the earlier of one year after the grant date or the company’s next Annual General Meeting of Shareholders.

On the same date, he was also granted 2,071 common shares as part of his director-elected annual retainer for serving as a director. Following these awards, the filing shows direct ownership entries of 8,013 shares and 6,686 shares tied to the respective transactions.

Rhea-AI Summary

Posner Brian S reported acquisition or exercise transactions in this Form 4 filing.

Arch Capital Group Ltd. director Brian S. Posner received a grant of 2,071 restricted common shares. The award carried a price of $0.00 per share, indicating it was compensation rather than an open-market purchase.

According to the grant terms, these restricted shares will vest on the earlier of one year after the grant date or Arch Capital Group Ltd.'s next Annual General Meeting of Shareholders. Following this award, Posner directly owns 122,175 common shares of the company.

Rhea-AI Summary

MOCZARSKI ALEXANDER S reported acquisition or exercise transactions in this Form 4 filing.

ARCH CAPITAL GROUP LTD. director Alexander S. Moczarski received a grant of 2,071 restricted common shares of the company. The grant price is shown as $0.00 per share, indicating a share award as part of his compensation rather than an open-market purchase.

After this award, he directly holds 4,037 common shares. According to the restricted share agreement, these shares will vest on the earlier of one year after the grant date or Arch Capital Group Ltd.'s next Annual General Meeting of Shareholders, tying vesting to continued board service and the company’s shareholder meeting cycle.

Rhea-AI Summary

MALLESCH EILEEN A reported acquisition or exercise transactions in this Form 4 filing.

ARCH CAPITAL GROUP LTD. director Eileen A. Mallesach received a grant of 2,071 common shares as equity compensation. The award was reported at a price of $0.00 per share, indicating a share grant rather than a market purchase. Following this grant, she directly holds 13,802 common shares. Under the restricted share agreement, these shares will vest on the earlier of one year after the grant date or the company’s next Annual General Meeting of Shareholders.

Rhea-AI Summary

KILCOYNE MOIRA A. reported acquisition or exercise transactions in this Form 4 filing.

Arch Capital Group Ltd. director Moira A. Kilcoyne reported receiving common share awards as equity compensation. On May 5, 2026, she was granted 1,327 common shares and a separate award of 2,071 common shares, both at a stated price of $0.00 per share, reflecting non-cash grants.

Footnotes state that some of these are restricted shares that will vest on the earlier of one year from the grant date or the company’s next Annual General Meeting of Shareholders, and that the awards form part of the director-elected annual retainer for board service.

Rhea-AI Summary

Houston Daniel Joseph reported acquisition or exercise transactions in this Form 4 filing.

ARCH CAPITAL GROUP LTD. director Daniel Joseph Houston reported two equity awards of common shares. He received grants of 1,327 and 2,071 restricted common shares at no cash cost as part of his annual retainer for serving as a director.

Under the restricted share agreement, these awards vest on the earlier of one year after the grant date or the company’s next Annual General Meeting of Shareholders. Following these awards, the filing shows updated direct common share holdings of 13,313 and 11,986 shares in the two reported positions.

Rhea-AI Summary

Goodman Laurie reported acquisition or exercise transactions in this Form 4 filing.

ARCH CAPITAL GROUP LTD. director Laurie Goodman received a grant of 2,071 common shares on May 5, 2026. The shares are restricted and will vest on the earlier of one year after the grant date or the company’s next Annual General Meeting of Shareholders. After this award, Goodman directly holds 37,573 common shares.

Rhea-AI Summary

Ebong Francis reported acquisition or exercise transactions in this Form 4 filing.

ARCH CAPITAL GROUP LTD. director Francis Ebong received a grant of 2,071 restricted common shares on May 5, 2026 at no purchase price. These restricted shares vest on the earlier of one year after the grant date or the company’s next Annual General Meeting of Shareholders, bringing his direct holdings to 12,878 shares.

Rhea-AI Summary

BUNCE JOHN L JR reported acquisition or exercise transactions in this Form 4 filing.

ARCH CAPITAL GROUP LTD. director John L. Jr. Bunce reported two equity compensation grants of common shares. He received 1,327 restricted common shares and 2,071 additional common shares, both at a stated price of $0.00 per share, as part of his director-elected annual retainer.

The restricted shares will vest on the earlier of one year after the grant date or the company’s next Annual General Meeting of Shareholders. Following these awards, his directly held common share balance reported in the filing exceeds 1.56 million shares.

Rhea-AI Summary

PASQUESI JOHN M reported acquisition or exercise transactions in this Form 4 filing.

ARCH CAPITAL GROUP LTD. director and Chair John M. Pasquesi reported new share awards and updated indirect holdings in common shares as of May 5, 2026. He received awards of 1,858 and 1,327 common shares as part of his director-elected retainers, and a further 2,071 common shares, all at a stated price of $0.0000 per share.

According to the footnotes, these granted shares were contributed to a revocable trust where he and his spouse serve as trustees and beneficiaries. One trust holding now totals 294,305 shares and another trust holding totals 292,447 shares, while a direct holding totals 2,071 shares. Additional indirect holdings are reported through a limited liability company, a family limited partnership, and other trusts.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. director Daniel Joseph Houston reported an open-market purchase of 5,300 common shares on April 30, 2026, at a weighted average price of $94.085 per share. Following this transaction, his direct ownership increased to 9,915 common shares of the company.

Rhea-AI Summary

Arch Capital Group Ltd. director Brian S. Posner reported an open-market sale of 3,000 Depositary Shares, Series G, on March 11, 2026, at a weighted average price of $17.115 per share. Each Depositary Share represents a 1/1,000th interest in a Series G Non-Cumulative Preferred Share.

After the sale, Posner directly holds 2,000 Depositary Shares, Series G, 3,000 Depositary Shares, Series F (each representing a 1/1,000th interest in a Series F Non-Cumulative Preferred Share), and 120,104 Common Shares.

Rhea-AI Summary

Arch Capital Group president David Gansberg exercised stock options and sold a portion of the resulting shares. He exercised options for 10,770 common shares at an exercise price of $18.90 per share and received the same number of common shares.

On the same day, he sold 5,907 common shares in open-market transactions at a weighted average price of $96.3715 per share, with individual prices ranging from $96.35 to $96.42. Following these transactions, he holds 336,559 common shares directly.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. CEO Nicolas Papadopoulo exercised stock options and sold the resulting shares. He exercised options for 21,930 common shares at an exercise price of $18.90 per share, then sold 21,930 common shares at a weighted average price of $96.3093 per share in open-market transactions. Following these transactions, he holds 871,594 common shares directly. The options exercised had been granted earlier and vested in three equal annual installments beginning on May 13, 2017.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. President Rajeh Maamoun reported two bona fide gift transfers of the company’s common shares. On the reported date, he disposed of 40,600 common shares in a direct transaction and 40,600 common shares held indirectly through an LLC. After these transactions, he held 428,378 common shares directly and 40,600 shares indirectly. A footnote explains that the shares were contributed to a wholly owned LLC, then the LLC interests were transferred for no consideration to two irrevocable trusts for the benefit of his descendants, and he disclaims beneficial ownership of the LLC-held shares except to the extent of any pecuniary interest.

Rhea-AI Summary

Arch Capital Group Ltd. president Rajeh Maamoun reported awards of both stock options and common shares. He acquired stock options for 24,475 shares at a price of $0.00 per share and was granted 6,843 common shares, also at $0.00 per share.

Following the common share award, his directly held common share position increased to 468,978 shares. The stock option grant becomes exercisable in three equal annual installments starting on March 3, 2027, with additional installments on March 3, 2028 and March 3, 2029, subject to the applicable award agreement.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. Chief Investment Officer Christine Todd reported equity awards on March 3, 2026. She acquired stock options for 14,238 shares and another option grant for 6,305 shares, each with an exercise price of $0.0000 per share. She also received a grant of 3,981 common shares, bringing her directly held common share ownership to 100,230 shares as of that date. According to a footnote, the stock options become exercisable in three equal annual installments starting on March 3, 2027, with additional installments on March 3, 2028 and March 3, 2029, subject to the applicable award agreement.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. officer of subsidiary Louis T. Petrillo reported multiple equity transactions. On March 3, 2026, he acquired 2,889 Common Shares, $.0011 par value per share, as a grant/award, bringing his directly held common shares to 159,520.

On the same date he received a grant of 10,331 Stock Options (Right to Buy), with 10,331 options outstanding after the grant. According to a footnote, this stock option becomes exercisable in three equal annual installments beginning March 3, 2027, with the next two installments on March 3, 2028 and March 3, 2029, subject to the applicable award agreement.

On March 4, 2026, 8,030 Common Shares were disposed of in a tax-withholding disposition at a price of $98.4200 per share, reducing his directly held common shares to 151,490. Separately, 100 Common Shares are reported as held indirectly "By Household" by his step sons, who share his household.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. reported that CFO and Treasurer Francois Morin acquired equity awards. On March 3, 2026, he received a stock option for 19,061 shares at an exercise price of $0.0000 per share and a grant of 5,329 common shares. The option becomes exercisable in three equal annual installments beginning March 3, 2027, with additional installments on March 3, 2028 and March 3, 2029, subject to the applicable award agreement. Following the grant, he directly held 298,788 common shares.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. President David Gansberg reported equity compensation changes. On March 3, 2026, he acquired 24,475 stock options at an exercise price of $0.0000 per share and 6,843 common shares as grant awards. The stock option becomes exercisable in three equal annual installments starting March 3, 2027, with additional installments on March 3, 2028 and March 3, 2029, subject to the award agreement. On March 4, 2026, 12,519 common shares were disposed of at $98.4200 per share in a tax-withholding transaction. Following these transactions, he held 331,696 common shares directly.

Rhea-AI Summary

Arch Capital Group Ltd. CEO Nicolas Papadopoulo reported two equity awards. He acquired a stock option for 76,243 shares at an exercise price of $0.00 per share and a grant of 21,318 common shares, both held directly. The option vests in three equal annual installments starting March 3, 2027, with additional installments on March 3, 2028 and March 3, 2029, subject to the award agreement.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. officer of a subsidiary, Louis T. Petrillo, reported a tax-withholding disposition of 312 common shares on February 27, 2026 at $100.15 per share. After this, he directly held 156,631 common shares and indirectly held 100 shares attributed to step sons in his household.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. President David Gansberg reported a tax-related share disposition under an equity award. On this Form 4, 553 common shares were withheld on February 27, 2026 at $100.15 per share to cover taxes. Following this non-open-market transaction, he holds 337,372 common shares directly.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. director and CEO Nicolas Papadopoulo received a grant of 46,674 common shares on February 24, 2026, classified as a grant or award acquisition at no stated price per share. Following this award, his direct holdings total 850,276 common shares, including 248 shares acquired on May 30, 2025 under the company’s Employee Share Purchase Plan.

Rhea-AI Summary

Rajeh Maamoun reported acquisition or exercise transactions in this Form 4 filing.

ARCH CAPITAL GROUP LTD. reported that President Rajeh Maamoun received a grant of 28,546 common shares on February 24, 2026 as an award, at a stated price of $0.0000 per share. Following this equity award, his directly held ownership increased to a total of 462,135 common shares.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. Chief Investment Officer Christine Todd was granted 25,046 common shares of the company on February 24, 2026 as an equity award, at a stated price of $0.0000 per share. Following this grant, her directly held stake increased to 96,249 common shares.

The reported holdings figure includes 248 common shares previously acquired on May 30, 2025 under the Arch Capital Group Ltd. Employee Share Purchase Plan, as noted in the filing footnote.

Rhea-AI Summary

ARCH CAPITAL GROUP LTD. officer of a subsidiary Louis T. Petrillo reported mixed equity movements in company common shares. On 2026-02-24, he received a grant of 17,136 common shares at $0.0000 per share, increasing his direct holdings to 156,943 shares.

On the same date, 412 shares were disposed of at $99.18 per share as a tax-withholding disposition, a transaction used to cover tax liabilities rather than an open-market sale. Separately, 100 shares are reported as indirectly owned by his household and are held by his step sons.

Rhea-AI Summary

Arch Capital Group Ltd. president David Gansberg reported two stock transactions in company common shares. He disposed of 509 shares in a tax-withholding transaction at $99.18 per share and received a grant of 28,546 shares at no cost, leaving him with 337,925 directly held shares.

Rhea-AI Summary

Morin Francois reported acquisition or exercise transactions in this Form 4 filing.

ARCH CAPITAL GROUP LTD. reported that CFO and Treasurer Francois Morin received a grant of 27,432 common shares on February 24, 2026 at no purchase price, as an award. Following this grant and prior employee share purchase plan adjustments, his direct holdings total 293,459 common shares.

Rhea-AI Summary

Arch Capital Group Ltd. president Maamoun Rajeh reported several equity transactions in the company’s common shares on February 11, 2026. He exercised stock options covering 15,930 shares at an exercise price of $27.0867 per share and additional options for 31,500 shares at $27.13 per share.

On the same day, he completed an open‑market sale of 47,430 common shares at a weighted average price of $96.1176 per share, executed across multiple trades within a disclosed price range. After these transactions, he directly owned 433,589 Arch Capital Group common shares.

Rhea-AI Summary

Arch Capital Group Ltd. director and chair John Pasquesi reported several December 2025 transactions in the company’s common shares. On December 12, 2025, a revocable trust for which he and his spouse are trustees and beneficiaries sold 28,866 shares at a weighted‑average price of $93.8094 and another block of 175,000 shares at a weighted‑average price of $93.9094. The filing also reports a gift of 53,000 shares coded as a transfer without consideration.

On December 15, 2025, the same trust sold an additional 8,800 shares at a weighted‑average price of $94.1686. Following these transactions, Pasquesi continues to beneficially own Arch Capital common shares both directly and through various entities, including revocable trusts, a family limited partnership and a limited liability company.

Rhea-AI Summary

Arch Capital Group Ltd. (ACGL) reported an insider equity transaction by its President, who is an officer of the company. On 11/19/2025, the reporting person disposed of 9,494 common shares of Arch Capital Group Ltd. at a price of $91.17 per share, according to the Form 4 filing. After this transaction, the officer directly beneficially owned 309,888 common shares, reflecting the updated holding position.

Rhea-AI Summary

Arch Capital Group Ltd. (ACGL) reported an insider transaction by a director on a Form 4. On October 30, 2025, the reporting person recorded gifts of common shares at a price of $0 per share, with individual entries of 877, 877, and 438 shares (transaction code G).

Following these transactions, the filing lists 192,807 common shares indirectly held by a revocable trust for which the reporting person and spouse serve as trustees. The filing also shows additional indirect holdings of 163,000 common shares by an irrevocable trust for which the spouse is a co‑trustee, and 53,000 common shares by an irrevocable trust for which the reporting person is a co‑trustee.